Ruiyuan Cao
发表
Wu Zhong,
Ruiyuan Cao,
Zhihong Hu,
2020,
Cell Research.
Junhai Xiao,
Ruiyuan Cao,
Yuhuan Li,
2013,
Molecules.
Yiming Li,
Lixia Chen,
Xingzhou Li,
2020,
Molecules.
Ruiyuan Cao,
Wu Zhong,
Dongmei Zhao,
2019
.
Ruiyuan Cao,
Wu Zhong,
Dongmei Zhao,
2016,
Molecules.
Jian-nan Feng,
Jiangxue Li,
Lulu Cai,
2020,
Signal Transduction and Targeted Therapy.
Ruiyuan Cao,
Wu Zhong,
Song Li,
2021,
Theranostics.
X. Ren,
Ruiyuan Cao,
Wu Zhong,
2022,
Antiviral research.
P. Horby,
Dayan Wang,
F. Hayden,
2020,
EBioMedicine.
Ruiyuan Cao,
Wu Zhong,
Song Li,
2020,
Bioorganic chemistry.
Zhìhóng Hú,
Mingyue Xu,
Manli Wang,
2020,
ACS infectious diseases.
Yafei Huang,
Ruiyuan Cao,
Z. Bi,
2014,
BMC Cancer.
Xingzhou Li,
Ruiyuan Cao,
Wu Zhong,
2016,
European journal of medicinal chemistry.
Yi Shi,
Ruiyuan Cao,
Wu Zhong,
2017,
Open forum infectious diseases.
Huan He,
Ruiyuan Cao,
Wu Zhong,
2020,
Organic & biomolecular chemistry.
Ke Xu,
Xingzhou Li,
Gang Zou,
2020,
Antimicrobial Agents and Chemotherapy.
F. Liu,
Lei Zhao,
Hui-Yan Li,
2019,
Cell reports.
Ruiyuan Cao,
Wu Zhong,
Song Li,
2021,
European journal of medicinal chemistry.
Jiang Li,
Zhìhóng Hú,
F. Dèng,
2022,
Antiviral research.
Y. Kumaki,
Ruiyuan Cao,
Wu Zhong,
2014,
Antiviral chemistry & chemotherapy.
X. Ren,
Ruiyuan Cao,
Wu Zhong,
2022,
Industrial Crops and Products.
Ruiyuan Cao,
Wu Zhong,
Huabin Hu,
2022,
Molecules.
Ruiyuan Cao,
Wu Zhong,
Wei Li,
2022,
Viruses.
Gengfu Xiao,
Zhìhóng Hú,
Mingyue Xu,
2020,
Virologica Sinica.
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
Gengfu Xiao,
Lin Zhu,
T. Gao,
2021,
Nature Communications.
Ruiyuan Cao,
Wu Zhong,
Wei Li,
2022,
Virologica Sinica.
Yun-ping Zhu,
Zhihong Wu,
Manli Wang,
2021,
Signal Transduction and Targeted Therapy.
Ruiyuan Cao,
Jun-hai Xiao,
Song Li,
2017,
Bioorganic & medicinal chemistry letters.
Xu Shen,
Xiao-min Luo,
Yu Zhou,
2016,
European journal of medicinal chemistry.
Ruiyuan Cao,
Wu Zhong,
Shuang Cao,
2016,
Molecules.
Wu Zhong,
Ruiyuan Cao,
Ruiyuan Cao,
2015,
European journal of medicinal chemistry.
Guocheng Huang,
Menghao Huang,
Ruiyuan Cao,
2018,
European journal of medicinal chemistry.
Wu Zhong,
Li Chen,
Yang Yang,
2020,
Engineering.
Ruiyuan Cao,
Wu Zhong,
Xingjuan Chen,
2019,
Cells.
Gengfu Xiao,
Zhìhóng Hú,
Mingyue Xu,
2020,
Cell Research.
Zhìhóng Hú,
Mingyue Xu,
Manli Wang,
2020,
Cell Discovery.
Jiang Li,
Mingyue Xu,
Manli Wang,
2023,
MedComm.
J. Wen,
Ruiyuan Cao,
Wu Zhong,
2020,
Critical Care.
Zhìhóng Hú,
Xiulian Sun,
Mingyue Xu,
2020,
Cell Discovery.
Zhìhóng Hú,
Mingyue Xu,
Manli Wang,
2020,
Cell Discovery.
Ruiyuan Cao,
Wu Zhong,
Song Li,
2019,
European journal of medicinal chemistry.
Yun-ping Zhu,
Zhihong Wu,
Hongjun Li,
2020,
Signal Transduction and Targeted Therapy.
Ruiyuan Cao,
Wu Zhong,
Wei Li,
2022,
Viruses.
Yuanhua Liu,
Pei Hao,
Xuan Li,
2018,
BMC Genomics.
Shuyang Zhang,
Hongjun Li,
Jie Ma,
2021,
Signal Transduction and Targeted Therapy.
Zhihong Wu,
Shuyang Zhang,
Ruiyuan Cao,
2022,
Advanced science.
Yun-ping Zhu,
Zhihong Wu,
Lei-ke Zhang,
2020,
bioRxiv.
Ruiyuan Cao,
Wu Zhong,
Song Li,
2020,
ACS infectious diseases.
Zhìhóng Hú,
Xiulian Sun,
Mingyue Xu,
2020,
Cell Discovery.
Lin Zhu,
T. Gao,
Yaoning Liu,
2019,
Biochemical and biophysical research communications.
N. Xia,
T. Cheng,
Jun Zhang,
2019,
ACS infectious diseases.
Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68
Honglin Li,
T. Cheng,
Ruiyuan Cao,
2022,
Journal of medicinal chemistry.
Shibo Jiang,
Keliang Liu,
S. Xia,
2018,
Journal of medicinal chemistry.
Kuanglei Wang,
Kun Zhang,
Ruiyuan Cao,
2019,
European journal of medicinal chemistry.
Ruiyuan Cao,
Wu Zhong,
Wei Li,
2022,
Antiviral research.
Yafei Huang,
Ruiyuan Cao,
Z. Bi,
2014,
BMC Cancer.
Junlin He,
Ruiyuan Cao,
Chenhong Wang,
2023,
Molecules.
Wu Zhong,
Ruiyuan Cao,
Zhihong Hu,
2020,
Cell Discovery.
Xingzhou Li,
Ruiyuan Cao,
J. Che,
2021,
Bioorganic & medicinal chemistry.
Pei Hao,
Ruiyuan Cao,
Yuanhua Liu,
2018,
BMC Genomics.
Honglin Li,
Liqi Zhu,
Xuan Li,
2023,
Science China Life Sciences.
TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Lei Liu,
Zheng Zhang,
Minghui Yang,
2020
.
Ruiyuan Cao,
Wu Zhong,
Wei Li,
2023,
ACS nano.